Kythera Biopharmaceuticals LLC
(NASDAQ : KYTH)

( )
KYTH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.51%51.740.9%$2185.75m
JNJJohnson & Johnson 0.26%163.370.7%$1368.59m
MRKMerck & Co., Inc. -1.55%72.280.7%$1045.98m
BMYBristol-Myers Squibb Co. 0.50%57.121.0%$821.40m
LLYEli Lilly & Co. -0.47%245.181.1%$704.90m
ABBVAbbVie, Inc. 0.12%121.501.9%$637.74m
AZNAstraZeneca Plc -1.17%54.761.0%$308.93m
NVSNovartis AG 0.19%80.680.2%$173.62m
GSKGlaxoSmithKline Plc 1.51%42.390.2%$161.58m
DRNADicerna Pharmaceuticals, Inc. -0.05%38.160.3%$155.25m
VTRSViatris, Inc. -0.32%12.400.0%$148.00m
RPRXRoyalty Pharma Plc 1.74%38.550.1%$119.40m
BFRIBiofrontera, Inc. 2.82%4.370.0%$116.32m
RGENRepligen Corp. 4.48%258.676.7%$97.18m
NVONovo Nordisk A/S 2.24%110.160.1%$84.66m

Company Profile

KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California. KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.